Article Information
History
- November 22, 2022.
Article Versions
- Version 1 (September 15, 2022 - 12:16).
- You are currently viewing Version 2 of this article (November 22, 2022 - 02:51).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sayanika Banerjee1,*,
- Julia K Varga2,*,
- Manoj Kumar1,
- Guy Zoltsman3,
- Michail N Isupov4,
- Rina Rosenzweig3,
- Ora Schueler-Furman2,# and
- Reuven Wiener1,#
- 1Department of Biochemistry and Molecular Biology, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
- 2Department of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel
- 3Department of Chemical and Structural Biology, Weizmann Institute of Sciences, Rehovot, Israel
- 4The Henry Wellcome Building for Biocatalysis, Biosciences, University of Exeter, Stocker Road, Exeter, EX4 4QD, United Kingdom
- ↵#To whom correspondence should be addressed: ora.furman-schueler{at}mail.huji.ac.il, reuvenw{at}ekmd.huji.ac.il
↵* These authors contributed equally to this work
Posted November 22, 2022.
AlphaFold2-based fusion design deciphers crucial role of the E3 UFL1 N-terminal helix in E2 UFC1 binding and ufmylation
